De Barros et al. reported the first analysis of PSMA-targeted radioguided surgery (RGS) using the drop-in gamma probe in patients with lymph node (LN) recurrent prostate cancer, with a sensitivity of 86% and a specificity of 100% [21]. This evidence concerns the gene FOLH1 and prostate carcinoma.